These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2317435)

  • 1. ACE inhibitors and diuretics causing hypokalaemia.
    D'Costa DF; Basu SK; Gunasekera NP
    Br J Clin Pract; 1990 Jan; 44(1):26-7. PubMed ID: 2317435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group.
    Bergler-Klein J; Sochor H; Pouleur H; Pacher R; Porenta G; Glogar D
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):194-8. PubMed ID: 7526050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypokalaemia in the elderly: is it always diuretic-induced?
    Nasar MA; Lyle EM
    Br J Clin Pract; 1994; 48(1):19-21. PubMed ID: 8179975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuretics potentiate angiotensin converting enzyme inhibitor-induced acute renal failure.
    Mandal AK; Markert RJ; Saklayen MG; Mankus RA; Yokokawa K
    Clin Nephrol; 1994 Sep; 42(3):170-4. PubMed ID: 7994935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac insufficiency: what treatment? what dose? For which patients? Converting enzyme inhibitors and diuretics].
    Komajda M
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():13-6. PubMed ID: 10830083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of cardiac failure with angiotensin-converting enzyme inhibitors and diuretics].
    Deray G; Martinez F; Jacobs C
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):735-40. PubMed ID: 8760660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
    Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
    J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone in severe heart failure: enhances efficacy of diuretic + ACE inhibitor combinations.
    Prescrire Int; 2000 Oct; 9(49):158-9. PubMed ID: 11603418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypokalaemia and sudden cardiac death--lessons from implantable cardioverter defibrillators.
    Maeder M; Rickli H; Sticherling C; Widmer R; Ammann P
    Emerg Med J; 2007 Mar; 24(3):206-8. PubMed ID: 17351228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
    Klaus D
    Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
    Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
    J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy for hypertension in the elderly.
    Kligman EW; Higbee MD
    J Fam Pract; 1989 Jan; 28(1):81-7. PubMed ID: 2563274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal function during treatment of chronic renal failure with angiotensin converting enzyme inhibitors].
    Heitmann M; Rasmussen K; Nielsen JI; Møgelvang JC
    Ugeskr Laeger; 1995 Sep; 157(39):5381-4. PubMed ID: 7483050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacologic treatment of chronic congestive heart failure].
    Halawa B
    Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
    Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
    J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of heart failure. Digitalis, diuretic plus ACE inhibitor or more?].
    Becker H; Sigmund M
    Internist (Berl); 1995 Dec; 36(12):1117-23. PubMed ID: 8567216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.